Log in
Enquire now
‌

US Patent 11278709 Drug delivery device and methods for using same

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112787090
Patent Inventor Names
Franciscus Koppenhagen0
Seth Oringher0
Serena Kim0
Michael Frost0
Ashanthi Mathai0
Date of Patent
March 22, 2022
0
Patent Application Number
174630790
Date Filed
August 31, 2021
0
Patent Citations
‌
US Patent 10441538 Liquid naloxone spray
Patent Citations Received
‌
US Patent 12017026 Drug delivery device and methods for using same
0
‌
US Patent D956218 Drug applicator with a cap
0
Patent Primary Examiner
Tatyana Zalukaeva
Tatyana Zalukaeva
0
CPC Code
‌
A61K 31/485
0
‌
A61K 9/0043
0
‌
A61M 2210/0618
0
‌
A61M 31/00
0

Devices for intranasal administration of naloxone are disclosed. The devices comprise a foam applicator and are configured to locate an applicator comprising a naloxone composition. in proximity to the middle turbinate and/or inferior turbinate. Naloxone can be delivered to the nasal mucosa by squeezing the nostril against the applicator. The device and methods of using the devices can be used to treat an opioid overdose.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11278709 Drug delivery device and methods for using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.